UNSPSC 51411804: Co-dergocrine mesilate or dihydroergotoxine mesylate or ergoloid mesylate

This classification denotes a vasodilating agent with the molecular formula C20H29N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X3S33EX3KW, chemically known as (6aR,9R,10aR)-N-[(2S)-1-hydroxypropan-2-yl]-7-methyl-6,6a,8,9,10, 10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid, but generally known as ergoloid mesylates, which bears US NIH Compound Identifier 49800049. SMILES: CC(CO)NC(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C.CS(=O)(=O)O.

UNSPSC 51411804 Co-dergocrine mesilate or dihydroergotoxine mesylate or ergoloid mesylate is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The City of Tampa's sealed-bid solicitation (26P00188, due April 8, 2026) for Advanced Life Support Medications targets epinephrine, labetalol, adenosine, and diltiazem — acute emergency pharmaceuticals with no relationship to ergoloid mesylate, a cognitive-enhancement agent used in geriatric care. The code appears misapplied to emergency medical supply procurement.

No recent state and local opportunities support procurement of ergoloid mesylate or its variants. The single posted record reflects a data-taxonomy mismatch rather than genuine activity under this Commodity code. Until additional opportunities emerge that correctly map to ergoloid mesylate sourcing, this code shows no actionable market signal for state and local vendors.